Rockwell (RMTI), NxStage (NXST) Enter Manufacturing Agreement
- Dick's Sporting Goods, Inc. (DKS) Reports In-Line Q4 EPS; Issues Mixed Q1, FY14 Outlook
- Pre-Open Stock Movers 3/11: (LJPC) (BYD) (FCEL) Higher; (FTEK) (RTK) (MYGN) Lower (more...)
- Apple (AAPL) Pressures Labels for More Exclusive Music Deals as iTunes Growth Flattens
- American Eagle Outfitters (AEO) Tops Q4 EPS by 1c; Issues Weak Q1 Outlook
- Tesla (TSLA): 'Defending Innovation and Consumer Choice in New Jersey'
Rockwell Medical Technologies (NASDAQ: RMTI) has signed a contract with NxStage Medical, Inc. (Nasdaq: NXST) to manufacture dialysate concentrate for the NxStage System One", the first and only truly portable hemodialysis system cleared for home use by the U.S. Food & Drug Administration. The contract term is for two years.
You May Also Be Interested In
- Oramed Pharma (ORMP) Receives Third Austrialian Patent for ORMD-0901
- Rexahn Pharma (RNN) Reports MTD Not Yet Achieved in Supinoxin Phase I; No Adverse Events Reported
- Incyte (INCY) Reports Ruxolitinib Met Primary Endpoint in Phase III for Polycythemia Vera
Create E-mail Alert Related CategoriesCorporate News, FDA
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!